10x Genomics Gross Margin 2018-2024 | TXG

10x Genomics gross margin from 2018 to 2024. Gross margin can be defined as a company's total sales revenue minus its cost of goods sold, divided by the total sales revenue, expressed as a percentage.

10x Genomics Gross Margin 2018-2024 | TXG

10x Genomics gross margin from 2018 to 2024. Gross margin can be defined as a company's total sales revenue minus its cost of goods sold, divided by the total sales revenue, expressed as a percentage.
Related Stocks
Company NameMarket
Cap
Tempus AI (TEM)$8.5B
Inspire Medical Systems (INSP)$5.3B
Hims & Hers Health (HIMS)$5.1B
Privia Health (PRVA)$2.5B
Enovis (ENOV)$2.5B
IRhythm Technologies (IRTC)$2.4B
Azenta (AZTA)$2B
Omnicell (OMCL)$2B
Clover Health Investments (CLOV)$1.6B
Schrodinger (SDGR)$1.4B
Phreesia (PHR)$1.1B
Butterfly Network (BFLY)$650M
Standard BioTools (LAB)$562M
Talkspace (TALK)$522M
Fulgent Genetics (FLGT)$520M
Definitive Healthcare (DH)$483M
Health Catalyst (HCAT)$459M
TruBridge (TBRG)$244M
Pulmonx (LUNG)$237M
SOPHiA GENETICS SA (SOPH)$214M
American Well (AMWL)$122M
EUDA Health Holdings (EUDA)$107M
P3 Health Partners (PIII)$75M
HeartBeam (BEAT)$67M
111 (YI)$53M
CareCloud (CCLD)$46M
Zepp Health (ZEPP)$40M
SHL Telemedicine (SHLT)$40M
Outset Medical (OM)$39M
Movano (MOVE)$20M